CRWV CoreWeave, Inc.
CoreWeave, Inc. operates as a cloud infrastructure technology company in the United States, Denmark, Middle East and Asia Pacific. The company offers CoreWeave Cloud platform that comprises proprietary software and cloud services that deliver the automation and efficiency needed to manage complex artificial intelligence (AI) infrastructure at scale. It also offers data and storage solutions, such as Local Object Transport Accelerator; infrastructure control solutions, including CoreWeave Kubernetes service; mission control services, including node, rack, and fleet lifecycle management; model and agent development tools comprising Weights & Biases, an AI developer platform; and runtime acceleration. In addition, the company offers graphics processing unit compute, CPU compute, networking services, managed services, and virtual and bare metal servers. Its services also include visual effects rendering, machine learning, pixel streaming, and batch processing. It has a collaboration with AdaniConneX to operate a data center in India. The company was formerly known as Atlantic Crypto Corporation and changed its name to CoreWeave, Inc. in December 2019. CoreWeave, Inc. was incorporated in 2017 and is based in Livingston, New Jersey.…
Industry Peers
Software - InfrastructureKey Statistics
About CoreWeave (NASDAQ: CRWV)
›
CoreWeave (NASDAQ: CRWV) is listed on Nasdaq, where its shares trade in USD. It belongs to the Software - Infrastructure industry, part of the Technology sector, and reports about 2,189 employees.
The shares were at 44.91 USD on 19 November 2026, down 40.0% over 52 weeks. Its 52-week range is 40.58 USD to 138.25 USD: the price is 67.5% below the high and 10.7% above the low.
Its market capitalisation is 24.98B USD.
CoreWeave reports return on equity of -35.0%, an operating margin of -0.5% and revenue up 168.2% year over year.
Its debt exceeds its cash by 61.99B USD, a debt-to-equity ratio of 8.94. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 38 analysts cover the stock, with an average rating of Buy; their mean price target of 115.34 USD is 156.8% above the current price. The next earnings report is expected on 25 February 2027.